StockData
Royalty Pharma plc logo

Royalty Pharma plc (RPRX) income statement

RPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/3053% above fair value
$68.45+0.73 (+1.08%)

Close on Nov 20, 2026Market cap $39.36BP/E 38.9Yield –

See a number that looks wrong?